ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that its management team's presentation at Jefferies' 2024 Global Healthcare Conference will now begin at 3:30 PM ET on Thursday, June 6, 2024. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be availa...
ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "Company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it completed the redemption of its outstanding publicly traded warrants (the “Public Warrants”) to purchase shares of the Company's common stock, par value $...
ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Jefferies' 2024 Global Healthcare Conference in New York, NY. The presentation will begin at 4:00 PM ET on Thursday, June 6, 2024. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be disp...
ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, previously announced on April 18, 2024, that it will redeem all of its publicly traded warrants (the “Public Warrants”) to purchase shares of Class A common stock, par va...
Mirion Technologies, Inc. (NYSE:MIR ) Q1 2024 Earnings Conference Call May 1, 2024 9:00 AM ET Company Participants Alex Gaddy - Senior Vice President, Strategy and Investor Relations Tom Logan - Chief Executive Officer Brian Schopfer - Chief Financial Officer Conference Call Participants Chris Moore - CJS Securities Vlad Bystricky - Citigroup Andy Kaplowitz - Citigroup Yuan Zhi - B. Riley Secur...
ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the first quarter ended March 31, 2024. “The first quarter was a solid start for Mirion in 2024,” stated Thomas Logan, Mirion's Chief Executive Office...
ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it will redeem all of its publicly traded warrants to purchase shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), that...
ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024. Following the news release, the company will host a conference call the next day, Wednesday, May 1, 2024, at 9:00 am ET to discuss the results. Participants may access the call by dialing 1-844-826-3035 or 1-412-317-5195, and r...
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.